Holdings

Sofinnova Investments, Inc.

As of Sep 30, 2026, Sofinnova Investments, Inc. reported 53 positions worth US$1.81B. Largest: Natera, Inc., Genmab A/S and Vera Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Natera, Inc.1.55MUS$641Mno changeSep 30, 2026
Genmab A/S4.35MUS$155M+304KSep 30, 2026
Vera Therapeutics, Inc.2.79MUS$90.2Mno changeSep 30, 2026
Axsome Therapeutics, Inc.446KUS$82.2M+285KSep 30, 2026
Seaport Therapeutics, Inc.3.56MUS$71.9Mno changeSep 30, 2026
Rapport Therapeutics, Inc.1.9MUS$64Mno changeSep 30, 2026
ArriVent BioPharma, Inc.1.7MUS$51.4Mno changeSep 30, 2026
Rhythm Pharmaceuticals, Inc.535KUS$50.9M+127KSep 30, 2026
Eli Lilly and Company43,777US$50.7MnewSep 30, 2026
Dyne Therapeutics, Inc.2.51MUS$40.5M+853KSep 30, 2026